ANNUAL REVIEW 2025 | 15 YEARS OF CMAC

Fifteen years of transforming how medicines are made.

From digital-first process design and self-driving DataFactories to sustainable manufacturing and advanced material insights, here's how our research, training, facilities and industry partnerships delivered in 2025.

Screenshot of the annual report homepage 2025 edition
Screenshot of the annual report homepage 2025 edition

64 pages. Published September 2026. Also available as an accessible text version.

50+

Events and visits hosted onsite in 2025

170

Staff, researchers, academics and PhD students

15

Years since CMAC was founded in 2011

£200m

Cumulative funding investment in CMAC

60

Partners across industry, academia and technology

CMAC researchers discussing a process workflow on a large screen.

WELCOME FROM THE DIRECTOR

“CMAC's vision, collaboration and commitment remain strong, driving innovation at scale and shaping the future of pharmaceutical manufacturing.”

Prof. Alastair Florence, Director, CMAC

EXPLORE THE REVIEW

Four pillars. One mission.

Jump straight to the chapter you need. Each link opens the PDF at the right page

01

Research Excellence and Intensity

MediForge, SolvIT, DM² Accelerator, DDMAP and our digital CMC portfolio.

Read chapter - pp. 16-37

02

Outstanding Skills Development

Our MSc, the CEDAR CDT, Living Labs and the SkillsFactory platform.

Read chapter - pp. 38-43

03

World-Class Facilities

Investment, new equipment, the Data Lab and our journey to net zero.

Read chapter - pp. 44-49

04

Translation to Industry

OpenCMC™, PhD@Work and a case study in spherical agglomeration.

Read chapter - pp. 50-57

HIGHLIGHTS FROM 2025

The stories behind the numbers

Researcher operating laptop and automated robot in lab

HEADLINE PROGRAMME | MEDIFORGE

Advancing an Industry 5.0 future for sustainable medicines manufacturing

In its second year, the £11m programme has shown replicable flow synthesis across Leeds and Strathclyde, secure FAIR data sharing, and early integration of crystallisation, tableting and dissolution.

Read the MediForge story

RESEARCH | DM² ACCELERATOR

Scaling digital CMC for smarter, faster medicines

Six demonstration trials with partners including AstraZeneca, Shionogi and Lonza, plus a live Knowledge Graph.

6 industry demonstration trials delivered

Researchers showcasing HoloLens equipment to colleagues

RESEARCH | SolvIT

Designing greener solvents for API manufacture

With Imperial College London and Lilly, SolvIT combines modelling and experiments to cut solvent waste and cost.

100kg hazardous waste per 1kg of API: the problem we are tackling


FACILITIES | NET ZERO

Labs that measure and cut their own footprint

Real-time energy monitoring across 250+ assets, more efficient instruments and lab automation.

15.5 tCO₂e saved per year

Female lab operator holding test tube

Collaboration that drives progress

We co-create and co-deliver with partners across global pharma, technology providers and academia. Thank you to everyone who made 2025 possible.

Work with us

Explore partnership, facility access and collaborative research opportunities with CMAC.

Get next year’s review

Sign up to the CMAC newsletter for news, events and publications.